Eviagenics' Series A - II Round

Eviagenics raised a round of funding on February 09, 2011.

Eviagenics is a biotech company generating new products and manufacturing processes for the chemical and pharmaceutical industry by applying an in vivo recombination technology.…

Articles about Eviagenics' Series A - II Round: